Gyre Therapeutics (GYRE) Receivables - Other (2023 - 2025)
Historic Receivables - Other for Gyre Therapeutics (GYRE) over the last 6 years, with Q3 2025 value amounting to $200000.0.
- Gyre Therapeutics' Receivables - Other fell 8461.54% to $200000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $200000.0, marking a year-over-year decrease of 8461.54%. This contributed to the annual value of $200000.0 for FY2024, which is 8461.54% down from last year.
- As of Q3 2025, Gyre Therapeutics' Receivables - Other stood at $200000.0, which was down 8461.54% from $230000.0 recorded in Q2 2025.
- Gyre Therapeutics' 5-year Receivables - Other high stood at $1.3 million for Q1 2024, and its period low was $200000.0 during Q4 2024.
- In the last 3 years, Gyre Therapeutics' Receivables - Other had a median value of $300000.0 in 2023 and averaged $695555.6.
- In the last 5 years, Gyre Therapeutics' Receivables - Other soared by 33333.33% in 2024 and then crashed by 8461.54% in 2025.
- Gyre Therapeutics' Receivables - Other (Quarter) stood at $1.2 million in 2023, then plummeted by 83.33% to $200000.0 in 2024, then changed by 0.0% to $200000.0 in 2025.
- Its Receivables - Other stands at $200000.0 for Q3 2025, versus $230000.0 for Q2 2025 and $230000.0 for Q1 2025.